ISTP, 4901 Searle Parkway, Skokie, Il 60077

Cyclopure Commercialization

The team aims to take their technology into several markets. There is the consumer point-of-use market (think of home systems that use carbon to purify water). The company plans to sell branded products through its e-commerce website.

In parallel with commercialization of the first generation of water treatment products, the company continues to invest heavily in research and development to improve the performance and value of its cyclodextrin adsorbents. Cyclopure’s scientists have modified their cyclodextrin adsorbents to target specific contaminants. After targeting pharmaceuticals and pesticides with its technology, the company’s chemists designed a second adsorbent named, DEXSORB+ and will be used for municipal applications. Today, its pilot scale production at the lab is producing 60 kilograms per month, enabling them to push out its commercial products, analytical and home activities. The company is launching its second home water test kit for pharmaceuticals and pesticides.

“If we can get people to trust in their tap again, with a cost effective solution, it’s a home run for everybody,” Frank Cassou, chief executive officer of Cyclopure said. “We are all trying to preserve water, be efficient in times where there’s growing populations. We want to bring a solution to the household that is healthy, affordable, and sustainable.”

For more insights on Cyclopure, click here.

Comments Off on Cyclopure Commercialization Blog

Read more

Chicago Area Life Science Cluster

A life sciences cluster has also grown in recent years in and around Chicago, where three federal laboratories, several biopharma giants, and an emerging community of startups are buttressed by a strong base of academic research institutions—including Northwestern University, the University of Chicago, and the University of Illinois.

The bioscience industry’s economic footprint reaches into so many local communities across the country. From capital investments to research & development, this report shows the impact of the biosciences across the nation’s innovation ecosystem.

In Illinois, life sciences employers grew their employment base since 2016, increasing by 3.2 percent reaching nearly 88,000 direct jobs. Research also ranked in the top tier of all states in life sciences related academic R&D activities. Illinois research institutions spent nearly $1.6 billion in 2018 on R&D.

“The bioscience industry is critically important to Illinois and we are proud to work closely with partners like iBIO to help ensure the future of the industry and its role as an economic driver in the region,” said Pete Pellerito, BIO Senior Policy Adviser for Federal and State Economic Development and Technology Transfer Initiatives. To access the entire article, click here.

Comments Off on Chicago Area Life Science Cluster Blog

Read more

Vetter Celebrates 10 Years @ISTP

At the time of its creation, the Skokie facility employed approximately 15 German expats to support the setting up of the core processes at the site. Today, the facility has a working staff of around 100 employees, almost all of whom are from the US. In addition to its growing employee population, the facility has also doubled in size from its original 24,000 sq. ft. to 50,000 sq. ft. today. To access the press release, click here.

“Our Skokie facility is a clear demonstration of the successful strategy we put into place in the second half of the 2000s,” said Vetter Managing Director Thomas Otto “That strategy was to be closer to the injectable development projects taking place in the US. The facility is also further proof of our family related business philosophy. By bringing expats to the facility first, and then gradually transitioning primarily to local employees, we created strong intercultural teams and secured knowledge transfer from our German specialists to our US experts.”

Vetter Development Service Chicago has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug products from early stages to Phase II, with transfer to the company’s commercial manufacturing capabilities in Europe. As a strategic partner with a global network of excellence, Vetter provides proven drug delivery systems specifically designed for the clinical needs and timelines of complex compounds. For more on Vetter’s Chicago site, please see: https://www.vetter-pharma.com/en/clinical-manufacturing-us

Comments Off on Vetter Celebrates 10 Years @ISTP Blog, News

Read more

New Downtown Skokie TIF

As noted in the Winter 2020 edition of Skokie Biz, the newly formed Oakton – Niles Tax Increment Finance (TIF) District was approved by the Skokie Village Board and has the unanimous support from all taxing jurisdictions.  The 6.25 acre TIF District was formed to spur transformational development of Downtown Skokie and the region around ISTP.

Construction on multiple projects is expected to begin in spring 2020, including a new combined public/private parking garage, a new 143-room Homewood Suites by Hilton Hotel and Conference Center and continued improvement to 8030 Lamon Ave at ISTP to accommodate new/or growing life science companies and research facilities.    Additionally, construction is underway at The BLVD, located at 8025 Skokie Blvd.  The development will feature 40 two bedroom luxury rental units and 2,600 square feet of ground floor commercial/retail space.

The Winter 2020 edition of Skokie Biz also noted additional new developments in Skokie such as the opening of an Amazon distribution center, new restaurant openings and other activities.  Click here to read the entire edition of SKOKIEBIZ

Comments Off on New Downtown Skokie TIF Blog, News

Read more

CycloPure – $1 million SBIR Grant

CycloPure, Inc., a leading innovator in water purification technologies and the developer of the DEXSORB™ line of adsorbents, announced that the National Institute of Environmental Health Sciences has awarded the company a Small Business Innovation Research (SBIR) Phase II grant in the amount of $1,000,000. CycloPure will use the Phase II grant to continue development of its DEXSORB+ adsorbent for removal of PFAS from drinking water.

“We’re thrilled to continue working with the NIEHS Superfund Research Program,” said CycloPure Chief Executive Frank Cassou. “NIEHS has been a great partner; they care deeply about the issue of PFAS in domestic drinking water supplies. Funds from this award come at a great time as we push to expand field activities with our environmental and municipal partners. We do our best work removing nanoscale contaminants. The PFAS Superfund Program is in our sweet spot.”

Click for entire release.

Comments Off on CycloPure – $1 million SBIR Grant Blog, News

Read more

Durbin & Pritzker Visit ISTP

At a press conference, Governor Pritzker recognized the contributions of the ISTP tenant community, American Landmark Properties and Village of Skokie as well as local members of the State Legislature. Additionally, the Governor highlighted Rebuild Illinois — a program that helps out every part of our state’s economy, and is a sustainable program that’s going to be paying dividends for years to come.

Pritzker announced at ISTP “Illinois now has a new message for the world. Illinois is back and we are open for business. Together we can build a state that truly serves as a beacon for families and businesses and good paying jobs.”

Senator Durbin met with representatives from ISTP and Park tenants, Vetter, Exicure, NuMat Technologies and the Village of Skokie

Durbin noted “I enjoyed getting the chance to meet with business leaders at the Illinois Science + Technology Park and learn more about the innovative work they are doing. I’ve made it a priority in Congress to support and increase federal funding for scientific research, which will help support ISTP’s innovators and inventors.”

After providing Durbin a look into the wet lab space at Exicure, CEO David Giljohann said “A great visit with a champion of science!”

Comments Off on Durbin & Pritzker Visit ISTP Blog, Events

Read more

Vetter’s Chicago Site Wins Award

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), announced that its US clinical manufacturing facility located at the Illinois Science+Technology Park in Skokie has been named as one of “Chicago’s Best and Brightest Companies to Work For®”.

The award, sponsored by the National Association for Business Resources, recognizes only those companies that have distinguished themselves as having the most innovative and thoughtful human resources approach. An independent research firm evaluates each company’s entry based on key measures in various categories which include among others, Compensation; Benefits and Employee Solutions; Employee Enrichment; Work-Life Balance; Communication and Shared Vision; Diversity and Inclusion, and Community Initiatives.

“Vetter is thrilled to be recognized for our efforts, particularly since the key parameters for deciding award winners are those of critical importance to our employees,” said Dr. Susanne Lemaine, President Vetter Development Services USA Inc. “This recognition reflects our ongoing efforts to perform consistently at a high level for our customers and to be an attractive company to work for in Chicago.”

Jennifer Kluge, President and CEO, Best and Brightest Programs said “..these companies rise to the challenge through their cultural innovation by maximizing their workforce potential.” .

To read the entire release, click here.

Comments Off on Vetter’s Chicago Site Wins Award Blog, News

Read more

SKOKIEBIZ Highlights Skokie Advantages

Skokie ranked high in this measurement of key economic development factors:

In July 2018, the Village conducted its triennial Nat ional Cit izen Survey (NCS), to gauge resident opinions on Village programs, services and policies. This survey is administered by the National Research Center to 1,600 randomly-selected Skokie residences and includes questions related to the business environment in Skokie, as a place to work, overall economic health of the community, shopping opportunities (usually highly rated!), employment opportunities, Downtown Skokie, and the overall quality of business and service establishments in
the community.

Survey Results:

  • 98% purchased goods and services in Skokie more than once a month.
  • 92-94% rated the overall economic health of the Village as positive.
  • 92% would recommend living/working in Skokie to someone who asked.
  • 90-93% rated Village efforts to implement economic development initiatives to bring new businesses, create new jobs, and generate sales taxes as positive.
  • 87-91% visited Downtown Skokie businesses more than once a month.
  • 84% rated the overall quality of business and service establishments as positive.
  • 83% rated Skokie as a positive place to work.
Click here to read the entire edition of SKOKIEBIZ

Comments Off on SKOKIEBIZ Highlights Skokie Advantages Blog, News

Read more

Vetter’s Skokie Facility Expansion nears Completion

Since beginning full operations in late 2011, Vetter’s US early-stage development site has been expanding to help meet growing customer demands.  A significant level of expansion activities are nearing completion at its US clinical manufacturing facility located at the Illinois Science & Technology Park. The ongoing growth of the facility will help satisfy existing and ever-increasing future customer requirements as well enable meet the complex needs of newer drug molecules like peptides or antibodies, many which need refrigeration or freezing. New offices with 45 work stations, conference rooms and an archive room are also included. To support the increase in customer projects, a permanent second work shift will be added in Visual Inspection over the next months. A second shift in Quality Oversight is also planned.

“This variety of activities is a further proof point of Vetter’s consistent strategic approach to stay ahead of the market by focusing on the important service needs of our customers during their drug development journey; promptness; flexibility; high yield of their valuable API and, of course high quality,” explains Dr. Claus Feussner, Senior Vice President of Vetter Development Service.  For more details, click here to access the entire press release. 

With the new additions, most of which are expected to be completed by April, the site will increase its storage space by an additional 3,100 sq. ft. The new storage includes a 2,500 sq. ft. freezer farm as well as a planned 600 sq. ft. walk-in refrigerator. In total, 6,800 sq. ft. of storage space will result. A second extension, now in the final planning stage, will include an additional 1,500 sq. ft. of room temperature and freezer space. “When completed, the facility will have more than double the overall storage space we have currently available. This extensive expansion of freezer and refrigeration storage space represents the ongoing evolution in our Chicago business,” summarizes Dr. Susanne Lemaine, Vice President Vetter Development Service Chicago.

For an overview of the history of Vetter, click here. 

Comments Off on Vetter’s Skokie Facility Expansion nears Completion Blog, News

Read more

Life Sciences Industry Growth

As noted in a recent CBRE report, the U.S. life sciences industry is growing at the fastest pace since 2000. The 3.2% year-over-year growth rate in U.S. life sciences employment ending Q3 2018 is a strong acceleration from the slow,but temporary, growth in early 2017 and well-above the 1.7% increase in total U.S. nonfarm employment over the same period. Employment in the industry has grown 42% over the past 20 years. All sectors of life sciences (Manufacturing, Testing Labs, R&D) are growing, but R&D continues to outperform.  The key subsector that is driving growth, even within the larger R&D sector, is research & development in biotechnology. This subsector grew at an annual pace of 6.2% in Q3 2018, far greater than other sectors of life sciences. Biotech R&D has grown 88% over the past 20 years.

An abundance of capital allocated to the life sciences industry is helping fuel strong growth. The $15.8 billion in annual life sciences venture capital funding through Q3 2018 was an 86% increase from the prior year. Though most of that funding was diverted to companies in Massachusetts and California, early indications show the share allocated to these states has waned over the past few years as investors seek greater opportunities elsewhere. Among segments of the life sciences industry attracting the most capital, about half of all funding is being allocated to biotechnology pursuits, clearly helping drive that subsector’s astonishing growth.  Click here to access the entire report

Comments Off on Life Sciences Industry Growth Blog, News

Read more